TVARDI THERAPEUTICS, INC. Cash and Restricted Cash
TVARDI THERAPEUTICS, INC. (TVRD) had Cash and Restricted Cash of $15.77 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.77M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.85M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.73M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.42M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $15.77M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $19.85M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $20.73M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $21.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $20.65M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $11.44M 10-Q · filed 2026-05-08 | $34.22M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $31.61M 10-Q · filed 2026-08-14 | $37.90M 10-K · filed 2025-03-11 |
| 2024-09-30 | $9.44M 10-Q · filed 2025-11-13 | $38.56M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $16.11M 10-Q · filed 2025-08-14 | $50.74M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $48.50M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $22.92M 10-K · filed 2026-03-31 | $53.68M 10-K · filed 2024-03-06 |
| 2023-09-30 | $64.78M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $60.16M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $47.80M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $64.15M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $43.21M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $47.13M 10-Q · filed 2023-08-07 | |
| 2022-03-31 | $21.77M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $13.86M 10-K · filed 2025-03-11 | |
| 2021-09-30 | $23.40M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $22.74M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $22.93M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $32.09M 10-K · filed 2024-03-06 | |
| 2020-09-30 | $75.69M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $57.38M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $17.44M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $18.71M 10-K · filed 2023-03-06 | |
| 2019-09-30 | $35.11M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $19.26M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $14.96M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $15.85M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $97.50M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $18.57M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $12.65M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $10.16M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $13.26M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $10.88M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $6.78M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $13.56M 10-K · filed 2020-02-27 | |
| 2015-12-31 | $15.80M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |